Cantor Fitzgerald analyst Dr Charles Duncan reiterated an Overweight rating and $43.00 price target on Alkermes (NASDAQ: ALKS).He said, "Trading ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE